Speaking at the 5th Precision Medicine in Inflammatory Bowel Summit

8:00 am - Wednesday 17th March 2027

Speakers:

Head of Translational Science & Medicine
Palisade Bio
Diagnostic Development Leader, Immunology
Johnson & Johnson Innovative Medicine
Senior Clinical Imaging Data Scientist
Roche
Head, Target Identification & Validation, Discovery Immunology
AbbVie
Head, Inflammatory Bowel Diseases, Global Evidence & Outcomes
Takeda Pharmaceutical
Vice President, Immunology Discovery
Merck
Head, Peptide Discovery, Immunology
AbbVie
Director & Head of Scientific, Precision Medicine Immunology Translation Research
AbbVie
Vice President, Early Clinical Development & Pharmacology
Mirador Therapeutics
Computational Scientist Lead
Sanofi
Director, Computational & Systems Biology
Takeda Pharmaceutical
Chief Scientific Officer
OSE Immunotherapeutics
Director, Computational Biology, Gastroenterology & Inflammation
Takeda Pharmaceutical
Senior Vice President, Clinical Development
Insilico Medicine
Professor, Gastroenterology
Amsterdam University Medical Centers
Chief Scientific Officer
Xencor
Chief Scientific Officer
Metagen Therapeutics
President, Chief Executive Officer & Board Member
AltruBio
Chief Medical Officer
Coultreon BioPharma
Co-Founder & Chief Technology Officer
Arda Therapeutics